LCS Webinar Instruction

Each webinar will last up to 20 minutes.
Webinar places are limited and will be offered on a first-come, first-served basis. Early registration is recommended.

The webinars are open for
– all interested persons
– persons who have actively subscribed for the LCS certification (Step 1 of the programme outline)

Monday, September 14, 2020 | 18:00 CET
An overview of LCS: A summary of the main trial results, from ELCAP to NELSON
Cornelia Schaefer-Prokop, Amersfoort/NL

Learning objectives:
After listening to the webinar, you will
– have learned about the differences between American NLST trial and the European trials in terms of study set up and how these differences influence the results
– be updated on the most recent screening trial results including the results of the Nelson trial presented at the IASLC in Toronto in 2018
– know about aspects to be considered when setting up a screening program
– will be informed about cost effectiveness analysis and statements of European professional societies as published thus far

Monday, October 19, 2020 | 18:00 CET
Technical requirements for LCS: How to perform the acquisition (dose, slice thickness), How to read the scans
Annemiek Snoeckx, Edegem/BE

Monday, November 23, 2020 | 18:00 CET
Solid nodule morphological evaluation: How to recognise obviously benign/malignant nodules, how to recognise intrapulmonary lymph nodes, pitfalls
Anand Devaraj, London/UK

This webinar will illustrate and discuss the crucial morphological features of solid lung nodules that help differentiate benign and malignant nodules and how they impact on management in screening.

Learning objectives:
– Understand that lung nodule management is determined mainly by nodule size and morphology
– Learn the key features of benign intrapulmonary lymph nodes
– Understand the appearances and management of inflammatory lesions
– Be aware of the CT morphological appearances of atypical lung cancers

Monday, December 14, 2020 | 18:00 CET
Solid nodule measurement and follow-up, criteria of positive screens
Helmut Prosch, Vienna/AT

Learning objectives:
– To become familiar with the pros and cons of 2D and 3D measurements of pulmonary nodules
– To understand the importance of module management protocols in lung cancer screening

Monday, January 18, 2021 | 18:00 CET
Subsolid nodules evaluation and follow-up, criteria of positive screens
Marie-Pierre Revel, Paris/FR

Learning objectives:
– To learn how to distinguish between pure ground glass and part-solid nodules
– To learn about the correlations between CT features and histopathology
– To learn about the criteria defining positive screen results and growth during follow-up
– To understand the importance of long term surveillance for non-resected subsolid nodules
– To be aware of the risk of overdiagnosis and overtreatment of subsolid nodules

Monday, February 22, 2021 | 18:00 CET
How to evaluate the coronary arteries and management of ancillary findings
Hans-Ulrich Kauczor, Heidelberg/DE

Learning objectives:
After listening to the webinar, you will
– have gained insight in the rationale of comorbidities and incidental findings of low dose CT in lung cancer screening
– have learnt about the significance of cardiovascular disease for mortality in the LCS population
– have consolidated knowledge about incidentals as being actionable, reportable and not-reportable
– be aware of potential harms: anxiety, cost and additional morbidity

Active members have access to the LCS webinar recordings below. Please login either at the right upper corner or by clicking on the respective video. If the access has been denied, please contact to check your membership status.